Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Byetta exenatide: Post-marketing study data

In a 1-year, 69-patient post-marketing study, Byetta improved beta cell function by 146% compared

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE